David Nelson
Senior Vice President for Health Affairs, UF & President, UF Health · University of Florida College of Medicine
Credentials: · ·
History
- 1996–1999
Gastroenterology
1993–1996- 1990–1993
1993 University of Massachusetts
Research
Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection
New England Journal of Medicine · 2014 · 1,119 citations
Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection
New England Journal of Medicine · 2014 · 930 citations
Hepatology · 2011 · 874 citations
38 papers
37 papers
- MS
29 papers
26 papers · 5 as a fellow
23 papers
23 papers
- KR
23 papers
22 papers
Grants
- 2004–2023
The Nomenclature of Human and Vertebrate Genes
National Human Genome Research Institute · U24
PI · $2.1M · University of Cambridge
- 2015–2019
Together: Transforming and Translating Discovery to Improve Health
National Center for Advancing Translational Sciences · UL1
Contact PI · $13.8M · University of Florida
- 2004–2018
Nomenclature of Human and Vertebrate Genes
National Human Genome Research Institute · U41
PI · $2.4M · European Molecular Biology Laboratory
- 2009–2015
UF Clinical and Translational Science Award
National Center for Advancing Translational Sciences · UL1
Contact PI · $12.2M · University of Florida
Clinical trials
- 2017–2020
Principal investigator · Completed · Phase 3
University of Florida
- 2016–2020
Study of Oral Treatments for Hepatitis C
Principal investigator · Completed · Phase 4
University of Florida
- 2011–2022
HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network
Principal investigator · Completed
University of North Carolina, Chapel Hill
- 2010–2014
Sorafenib Dose Ramp-Up in Hepatocellular Carcinoma (HCC)
Principal investigator · Completed · Phase 4
University of Florida